I think you missed my point on the last one. I live in canada, Hemp has been legal here for a long time. It's not some mystical new industry like some here seem to think.
It's a bulk agricultural commodity. It's cheap. It's cheaper to buy hemp in Canada than many other grains (Quinoa, cous cous etc)
Thus with this product, if they cannot make significant sales and inroads now, while it is young, fresh, hip and high margins, how will they do when it grows into an agricultural product rather than a 'health food' like it is now?
Furthermore, it is a spec stock, but it's a spec stock with a 100million+ price tag, based on an agricultural product rather than medical marijuana as it's forefront. It's bleeding cash and won't only need cash for expansion, but also just survival. It already has 3.3billion shares on issue. How much more dilution do you expect until profitability? is there a clear path to profitability?
@Pan head - I am not up to date with pot stocks, that's why I'm asking questions rather than stating facts. I just read the half yearly and from a business point of view it wasn't great, but you guys are presenting some of the more positive things for sure. I didn't know Medcan had a permit to export from the ODC? I thought it was discussed here and found that they didn't?
CGB Price at posting:
3.7¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
